Nano-X Imaging Ltd. (NNOX): R&D Expense
$19.24M
Year ended 2025-12-31
-10.1%
3-year compound annual growth
+15.9%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $19.24M | -4.7% | 2026-04-30, From 2025-01-01 |
| 2024-12-31 | $20.18M | -22.5% | 2026-04-30, From 2024-01-01 |
| 2023-12-31 | $26.05M | -1.7% | 2026-04-30, From 2023-01-01 |
| 2022-12-31 | $26.51M | +54.8% | 2025-04-09, From 2022-01-01 |
| 2021-12-31 | $17.12M | +85.9% | 2024-04-22, From 2021-01-01 |
| 2020-12-31 | $9.21M | +239.0% | 2023-05-01, From 2020-01-01 |
| 2019-12-31 | $2.72M | +304.3% | 2022-05-02, From 2019-01-01 |
| 2018-12-31 | $672.0K | n/a | 2021-04-06, From 2018-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Nano-X Imaging Ltd. (NNOX) | 2025-12-31 | $19.24M | -4.7% |
| CapsoVision, Inc (CV) | 2025-12-31 | $18.31M | +21.1% |
| Hyperfine, Inc. (HYPR) | 2025-12-31 | $17.45M | -22.4% |
| Escalon Medical Corp (ESMC) | 2025-06-30 | $753.1K | +9.4% |
| LogicMark, Inc. (LGMK) | 2025-12-31 | $617.4K | +10.5% |
| Nexgel, Inc. (NXGL) | 2025-12-31 | $2.0K | -97.4% |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | $7.57M | -56.4% |
| Biotricity Inc. (BTCY) | 2026-03-31 | $2.76M | +28.2% |
| Profound Medical Corp. (PROF) | 2025-12-31 | $20.60M | +21.4% |
Compare NNOX, CV, HYPR, ESMC side by side · Screen every company in X-Ray Apparatus & Tubes & Related Irradiation Apparatus ↗